<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01493063</url>
  </required_header>
  <id_info>
    <org_study_id>BRD/11/02-Y</org_study_id>
    <nct_id>NCT01493063</nct_id>
  </id_info>
  <brief_title>LACTACOL 01 - Impact of Breast Milk on the Neurodevelopment of Preterm Newborns</brief_title>
  <official_title>BRD/11/02-Y &quot;LACTACOL 01 - Impact of Breast Milk on the Neurodevelopment of Preterm Newborns&quot;.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to estimate the impact of the protein content of breastmilk at the
      end of hospitalization of the preterm newborn, on the neurodevelopment at 2 years old.

      The investigators expect a difference of at least 5 points of Development Quotient (DQ) when
      comparing extreme terciles of the protein content of breastmilk at the end of
      hospitalization.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">October 25, 2011</start_date>
  <completion_date type="Anticipated">April 2023</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To assess the impact of the protein content of human milk on the neuro-motor development of the preterm infant at 2 years of age</measure>
    <time_frame>At 2 years of age</time_frame>
    <description>ASQ (Ages and Stages Questionnaires) score at 2 years of age. The calculation of the sample size is only based on this endpoint. We wish to highlight a difference of at least 25 points of the ASQ score between both extreme terciles of protein concentration determined in breast milk at the end of hospitalization, when breastfeeding is exclusive (last sample of breastmilk before the end of hospitalization).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>To assess the impact of the protein content of human milk on the Body composition (%FAT MASS) and growth trajectory of the Preterm infant (from 0 to 2 years)</measure>
    <time_frame>End of hospitalization and at 2 years of age.</time_frame>
    <description>Body composition (%Fat mass) at the end of hospitalization
Growth trajectory of the Preterm infant (from 0 to 2)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Ancillary study 1.To assess the association between maternal eating habits(food intake during lactation estimated using the Food Frequency Questionnaire from the National French birth cohort ELFE), and the nutritional composition of human milk.</measure>
    <description>Association criterion between nutritional composition of human milk assessed by content determination of macro- and micronutrients, and omics approaches (metabolomics,…) and FFQ score</description>
  </other_outcome>
  <other_outcome>
    <measure>Ancillary study 2.To assess the chemical safety of human milk:identification of nutritional and environmental factors that could explain the presence of chemical contaminants;linking biological data and clinical data of mother and infant dyads</measure>
    <description>Level of chemical contamination of the human milk</description>
  </other_outcome>
  <other_outcome>
    <measure>Ancillary study N°3. Composition of breast milk and preterm infant's metabolic status and growth trajectory during the first weeks of life. Biomarkers identified in breastmilk and infant serum: lipidome, metabolome, miRNome, amino acids, oligosaccharides</measure>
    <description>Biomarkers identified in both biological materials (breastmilk and infant serum)</description>
  </other_outcome>
  <other_outcome>
    <measure>Ancillary study N°4. Study of the digested human milk during the first few weeks of life of the preterm infant</measure>
    <description>Composition in proteins and peptides of breastmilk before and after digestion by the infant</description>
  </other_outcome>
  <enrollment type="Actual">160</enrollment>
  <condition>Prematurity of Fetus</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Physiopathology</intervention_name>
    <description>Samples of breastmilk and infant serum</description>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Breastmilk samples et infant serum samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Preterm newborn
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Maternal decision of breastfeeding

          -  Born between 28 and 34 weeks of amenorrhea

          -  No important congenital pathology except prematurity

          -  Efficiency of the breastfeeding compatible with the research by the investigator

          -  Information and authorization of the parents or the parental authority

        Exclusion Criteria:

          -  Maternal decision of not breastfeeding

          -  Born before 28 weeks of amenorrhoea or after or at 34 weeks of amenorrhoea

          -  Important congenital pathology

          -  Efficiency of the breastfeeding incompatible with the research by the investigator

          -  Opposition from parents or the parental authority to participate to the research study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>28 Weeks</minimum_age>
    <maximum_age>34 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cécile Boscher, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Nantes</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital of Nantes</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 13, 2011</study_first_submitted>
  <study_first_submitted_qc>December 14, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 15, 2011</study_first_posted>
  <last_update_submitted>March 19, 2018</last_update_submitted>
  <last_update_submitted_qc>March 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>preterm infant</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

